Ing. Jan Šimoník
výzkumník I – Ústav biochemie
| e‑mail: |
|---|
Počet publikací: 16
2026
-
Data-Independent Acquisition Mass Spectrometry in Tumor Classification and Cancer Biomarker Research
Mass Spectrometry Reviews, rok: 2026, DOI
2025
-
DIA-MS identified transmembrane glycoprotein GPNMB as a candidate predictive biomarker and potentially a therapeutic target in metastatic renal cell carcinoma
Rok: 2025, druh: Konferenční abstrakty
-
Integrated multiomics classification of triple negative breast cancer
Rok: 2025, druh: Konferenční abstrakty
-
Integrated proteogenomic analysis identifies synuclein gamma as a key target of the mesenchymal stem-like subtype of triple negative breast cancer
Rok: 2025, druh: Konferenční abstrakty
-
Proteomics-driven multi-omics classification of triple negative breast cancer
Rok: 2025, druh: Konferenční abstrakty
2024
-
Breast cancer subclassification based on proteomics/proteogenomics for targeted therapy
Rok: 2024, druh: Konferenční abstrakty
-
Transmembrane glycoprotein GPNMB is a candidate predictive biomarker and potentially a therapeutic target in metastatic renal cell carcinoma
Rok: 2024, druh: Konferenční abstrakty
-
Understanding breast cancer biology via proteomics, proteogenomics and interactomics to identify novel therapy targets
Rok: 2024, druh: Konferenční abstrakty
2023
-
Next generation proteomics identifies a potential protein marker of poor response to tyrosine kinase inhibitors in metastatic renal cell carcinoma
Rok: 2023, druh: Konferenční abstrakty
-
Proteotype classification of localized and metastatic renal cell carcinoma for prognosis and therapy response
Rok: 2023, druh: Konferenční abstrakty